Company Filing History:
Years Active: 2000
Title: Inventor Profile: Mark Roger Crompton
Introduction
Mark Roger Crompton is a notable inventor based in London, Great Britain. With a solid background in biochemistry, he has contributed significantly to the field of protein tyrosine kinases. His innovative work has led to the development of at least one patented invention, showcasing his expertise in scientific research and application.
Latest Patents
Mark Roger Crompton holds a patent for "BRK protein tyrosine kinase and encoding nucleic acid." This invention pertains to the mechanisms of cellular signaling and has the potential to impact therapeutic strategies in treating various diseases.
Career Highlights
Crompton is currently employed at Glaxo Wellcome Inc., a prominent pharmaceutical company known for its commitment to research and development in health care. His work at Glaxo Wellcome has allowed him to be at the forefront of innovative drug discovery and development.
Collaborations
Throughout his career, Crompton has collaborated with several esteemed colleagues, including Barry Austin Gusterson and Philip John Mitchell. These partnerships have contributed to advancing research and enhancing the scientific community's understanding of protein functions and their implications in health.
Conclusion
Mark Roger Crompton remains a significant figure in the field of biotechnology, with his patent reflecting the ingenuity and impact of his work. As the landscape of medical research continues to evolve, his contributions will undoubtedly play a crucial role in shaping future innovations.